doi: 10.18632/aging.103064
Some clients benefit from weekly injections, while others may need them less often
By the time the full math shows up, youve already paid the first months membership
GLP-1 analogues as adjunctive therapy for type 1 diabetes: systematic review and meta-analysis (24 RCTs, N=3,377)
Potential downsides include mild side effects such as headaches, injection site irritation, or temporary appetite changes
In recent years, the pharmaceutical landscape has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as semaglutide and tirzepatide, offering promising outcomes in weight reduction for those struggling with obesity